Susquehanna International Group (Ireland)’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,500
Closed -$550K 72
2022
Q4
$550K Buy
+2,500
New +$458K 0.25% 34
2022
Q3
Sell
-4,000
Closed -$647K 104
2022
Q2
$647K Buy
+4,000
New +$625K 0.15% 45

Other funds holding ONC

Susquehanna International Group (Ireland)'s ONC Position: Q1 2023 in Review

Susquehanna International Group (Ireland) sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 2,500 shares — an estimated $550K sold.

Susquehanna International Group (Ireland) first reported a position in ONC in Q2 2022 and held it in 2 quarters. The position peaked at $647K in Q2 2022. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

  • Susquehanna International Group (Ireland) reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 2,500 BeOne Medicines Ltd shares in Q1 2023, an estimated $550K.
  • Susquehanna International Group (Ireland) first reported a position in BeOne Medicines Ltd in Q2 2022 and held it in 2 quarters.
  • Susquehanna International Group (Ireland)'s BeOne Medicines Ltd position peaked at $647K in Q2 2022.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q1 2023, filed 16 May 2023.